These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3829046)

  • 1. Construction and characterisation of a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids.
    Corvalan JR; Smith W
    Cancer Immunol Immunother; 1987; 24(2):127-32. PubMed ID: 3829046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific in vitro and in vivo drug localisation to tumour cells using a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids.
    Corvalan JR; Smith W; Gore VA; Brandon DR
    Cancer Immunol Immunother; 1987; 24(2):133-7. PubMed ID: 3829047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour therapy with Vinca alkaloids targeted by a hybrid-hybrid monoclonal antibody recognising both CEA and Vinca alkaloids.
    Corvalan JR; Smith W; Gore VA
    Int J Cancer Suppl; 1988; 2():22-5. PubMed ID: 3162442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulins secreted by a hybrid-hybridoma: analysis of chain assemblies.
    Smith W; Jarrett AL; Beattie RE; Corvalan JR
    Hybridoma; 1992 Feb; 11(1):87-98. PubMed ID: 1737643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The production of a bispecific anti-CEA, anti-hapten (4-amino-phthalate) hybrid-hybridoma.
    Lloyd F; Goldrosen M
    J Natl Med Assoc; 1991 Oct; 83(10):901-4. PubMed ID: 1800765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and expression of two mouse-human chimeric antibodies with high specificity and affinity for carcinoembryonic antigen.
    Arakawa F; Haruno M; Kuroki M; Kanda H; Watanabe T; Misumi Y; Matsuoka Y
    Hybridoma; 1993 Aug; 12(4):365-79. PubMed ID: 8244416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cDNA cloning and sequencing of a novel monoclonal antibody to carcinoembryonic antigen and construction of a mouse/human chimeric antibody.
    Shibaguchi H; Arakawa F; Imakiire T; Kuroki M; Kuroki M
    Anticancer Res; 2003; 23(6a):4383-8. PubMed ID: 14666725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased therapeutic effect of vinca alkaloids targeted to tumour by a hybrid-hybrid monoclonal antibody.
    Corvalan JR; Smith W; Gore VA; Brandon DR; Ryde PJ
    Cancer Immunol Immunother; 1987; 24(2):138-43. PubMed ID: 3829048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.
    Kuroki M; Kuroki M; Koga Y; Matsuoka Y
    J Immunol; 1984 Oct; 133(4):2090-7. PubMed ID: 6206151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity purification of novel bispecific antibodies recognising carcinoembryonic antigen and doxorubicin.
    Ford CH; Osborne PO; Mathew A; Rego BG
    J Chromatogr B Biomed Sci Appl; 2001 Apr; 754(2):427-35. PubMed ID: 11339286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humanisation and characterisation of PR1A3, a monoclonal antibody specific for cell-bound carcinoembryonic antigen.
    Stewart LM; Young S; Watson G; Mather SJ; Bates PA; Band HA; Wilkinson RW; Ross EL; Snary D
    Cancer Immunol Immunother; 1999 Feb; 47(6):299-306. PubMed ID: 10203059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse-human chimeric monoclonal antibody to carcinoembryonic antigen (CEA): in vitro and in vivo activities.
    Koga H; Kanda H; Nakashima M; Watanabe Y; Endo K; Watanabe T
    Hybridoma; 1990 Feb; 9(1):43-56. PubMed ID: 2312131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and high level expression of a chimeric antibody with specificity for human carcinoembryonic antigen.
    Beidler CB; Ludwig JR; Cardenas J; Phelps J; Papworth CG; Melcher E; Sierzega M; Myers LJ; Unger BW; Fisher M
    J Immunol; 1988 Dec; 141(11):4053-60. PubMed ID: 3141512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies to antitumor Vinca alkaloids: thermodynamics and kinetics.
    Pontarotti PA; Rahmani R; Martin M; Barbet J
    Mol Immunol; 1985 Mar; 22(3):277-84. PubMed ID: 4000131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies to carcinoembryonic antigen (CEA): characterization and use in a radioimmunoassay for CEA.
    Lindgren J; Hång B; Hurme M; Mäkelä O
    Acta Pathol Microbiol Immunol Scand C; 1982 Jun; 90(3):159-62. PubMed ID: 7113705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation, immunologic characterization and antitumor effects of human monoclonal antibodies for carcinoembryonic antigen.
    Imakiire T; Kuroki M; Shibaguchi H; Abe H; Yamauchi Y; Ueno A; Hirose Y; Yamada H; Yamashita Y; Shirakusa T; Ishida I; Kuroki M
    Int J Cancer; 2004 Feb; 108(4):564-70. PubMed ID: 14696121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial single-chain antibody fragments, specific for carcinoembryonic antigen.
    Ayala M; Dueñas M; Santos A; Vázquez J; Menéndez A; Silva A; Gavilondo JV
    Biotechniques; 1992 Nov; 13(5):790-9. PubMed ID: 1418981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: determination of affinities and specificities of monoclonal antibodies by using biotin-labeled antibodies and avidin as precipitating agent in a solution phase immunoassay.
    Wagener C; Clark BR; Rickard KJ; Shively JE
    J Immunol; 1983 May; 130(5):2302-7. PubMed ID: 6187848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid hybridomas producing bispecific antibodies to CEA and peroxidase isolated by a combination of HAT medium selection and fluorescence activated cell sorting.
    Jantscheff P; Winkler L; Karawajew L; Kaiser G; Böttger V; Micheel B
    J Immunol Methods; 1993 Jul; 163(1):91-7. PubMed ID: 8335963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers.
    Garambois V; Glaussel F; Foulquier E; Ychou M; Pugnière M; Luo RX; Bezabeh B; Pèlegrin A
    BMC Cancer; 2004 Oct; 4():75. PubMed ID: 15488142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.